---
title: 'The prognostic value of TMB in early-stage non-small cell lung cancer: a systematic
  review and meta-analysis'
date: '2023-09-05'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37667779/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20230906181400&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: 'CONCLUSION: The inherent prognostic role of TMB is limited in early-stage
  NSCLC. Ethnic differences in mutation burden must be considered while designing
  future trials on neoadjuvant immunotherapy. Further research in the harmonization
  and standardization of panel-based TMB is essential for its widespread clinical
  utility.Registration: ...'
disable_comments: true
---
CONCLUSION: The inherent prognostic role of TMB is limited in early-stage NSCLC. Ethnic differences in mutation burden must be considered while designing future trials on neoadjuvant immunotherapy. Further research in the harmonization and standardization of panel-based TMB is essential for its widespread clinical utility.Registration: ...